Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline - PubMed (original) (raw)
Affiliations
- PMID: 2202950
Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline
K Yanagihara et al. Oncogene. 1990 Aug.
Abstract
A new class of nontransformed revertant cells has been isolated from the ras-transformed cell line DT using cis-4-hydroxy-L-proline (CHP) as a selective agent. The new revertants, CHP 9CJ and CHP CB4, each contain two copies of the v-Ki-ras gene, elevated levels of phosphorylated p21ras protein, and rescuable transforming virus, indicating that the revertant phenotype observed in these cells does not result from inactivation of v-Ki-ras or inhibition of its expression. Both CHP 9CJ and CHP CB4 revertants show a greatly reduced ability to form colonies in soft agar and to produce tumors in syngeneic mice. CHP 9CJ cells are resistant to retransformation by ras and by additional oncogenes that do not encode tyrosine kinases. A comparison of oncogene resistance patterns in these CHP-derived revertants with those from our original ouabain-derived revertants fos C-11 and F-2 indicates that oncogenes may be divided into four general groups. Oncogenes that encode proteins structurally related to p21ras comprise the first group. The second group contains only tyrosine kinase-encoding oncogenes. The third group is composed of 'nuclear', e.g. fos, and 'cytoplasmic' serine-threonine-encoding oncogenes such as mos and raf. The fourth group contains the oncogenes sis and fms.
Similar articles
- Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
Ciardiello F, Sanfilippo B, Yanagihara K, Kim N, Tortora G, Bassin RH, Kidwell WR, Salomon DS. Ciardiello F, et al. Cancer Res. 1988 May 1;48(9):2483-91. Cancer Res. 1988. PMID: 2833347 - Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W, Heidecker G, Troppmair J, Yanagihara K, Bassin RH, Rapp UR. Kolch W, et al. Oncogene. 1993 Feb;8(2):361-70. Oncogene. 1993. PMID: 8426742 - Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ, Marx M, Calothy G, Blair DG. Topol LZ, et al. Cell Growth Differ. 1995 Jan;6(1):27-38. Cell Growth Differ. 1995. PMID: 7718484 - Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
Bortner DM, Langer SJ, Ostrowski MC. Bortner DM, et al. Crit Rev Oncog. 1993;4(2):137-60. Crit Rev Oncog. 1993. PMID: 8380545 Review. - Functional in vitro assays for the isolation of cell transformation effector and suppressor genes.
Zarbl H, Kho CJ, Boylan MO, Van Amsterdam J, Sullivan RC, Hoemann CD, Afshani VL. Zarbl H, et al. Environ Health Perspect. 1991 Jun;93:83-9. doi: 10.1289/ehp.919383. Environ Health Perspect. 1991. PMID: 1685446 Free PMC article. Review.
Cited by
- Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice.
Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. Yanagihara K, et al. Cancer Sci. 2004 Jul;95(7):575-82. doi: 10.1111/j.1349-7006.2004.tb02489.x. Cancer Sci. 2004. PMID: 15245593 Free PMC article. - Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts.
van der Geer P, Hunter T. van der Geer P, et al. EMBO J. 1993 Dec 15;12(13):5161-72. doi: 10.1002/j.1460-2075.1993.tb06211.x. EMBO J. 1993. PMID: 8262059 Free PMC article. - A radiation-induced murine ovarian granulosa cell tumor line: introduction of v-ras gene potentiates a high metastatic ability.
Yanagihara K, Nii M, Tsumuraya M, Numoto M, Seito T, Seyama T. Yanagihara K, et al. Jpn J Cancer Res. 1995 Apr;86(4):347-56. doi: 10.1111/j.1349-7006.1995.tb03063.x. Jpn J Cancer Res. 1995. PMID: 7775256 Free PMC article. - Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts.
Seliger B, Pfizenmaier K, Schäfer R. Seliger B, et al. J Virol. 1991 Nov;65(11):6307-11. doi: 10.1128/JVI.65.11.6307-6311.1991. J Virol. 1991. PMID: 1717721 Free PMC article. - Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.
Krauss RS, Guadagno SN, Weinstein IB. Krauss RS, et al. Mol Cell Biol. 1992 Jul;12(7):3117-29. doi: 10.1128/mcb.12.7.3117-3129.1992. Mol Cell Biol. 1992. PMID: 1535685 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous